CSF1 and breast cancer: CSF-1/CSF-1R inhibitors have been identified as therapeutic targets for a variety of malignant tumors, such as glioma, hepatocellular carcinoma, breast cancer, lung cancer and pancreatic cancer (27), and have broad application prospects in tumor immunotherapy (Table 1).